FitLine markets its Nutrient Transport Concept as a system that delivers nutrients "exactly when they are needed and where they are needed, to the cellular level." That promise anchors the brand's premium pricing across more than forty countries.
What the patent registry actually shows
The word "patented" appears routinely in distributor materials. Independent registries tell a narrower story.
NTC is a registered trademark. WIPO Madrid International Registration No. 1495693, filed by PM-International AG on 18 September 2019, covers the name and sign across classes including cosmetics, pharmaceuticals, and beverages. A trademark protects a name. It says nothing about how molecules cross cell membranes.
The company's verified patent portfolio contains roughly 22 granted patent families alongside 94 registered trademarks, according to independent IP databases. The patents cover formulations and compositions: a BioEnhancer blend, a GLP-1 booster formulation, elderberry extract combinations, a saffron-extract toothpaste, guaijaverin compositions, and a powdered beverage supplement. None of them specifies the NTC mechanism or describes how nutrients are preferentially delivered to the cell.
The closest piece of genuine absorption IP is German utility model DE202005003148U1, filed in February 2005, covering piperine as a catalyst for faster mineral and trace-element uptake. The filing lapsed in 2015. German utility models are registered without substantive examination for novelty.
PM-International's own communications cite "more than 70 national and international patents." Independent databases converge on roughly 22 granted families. The gap reflects standard industry practice: counting each national filing of an international patent family separately, plus pending applications not yet granted.
One attribution error recurs in NTC-adjacent searches. Three US patents, US 9,497,990, US 9,080,997, and US 8,851,365, are assigned to Iceberg Luxembourg SARL and inventor Eugenio Minvielle. They belong neither to PM-International nor to FitLine. Attributing them to either company is factually incorrect.
What the evidence shows
One FitLine product line has a credible evidence trail. König et al. (2019) published a double-blind, randomized clinical trial in Nutrients examining guava (Psidium guajava) extract, the core compound in FitLine C-Balance, for its effect on intestinal glucose resorption. Peak postprandial glucose rose 1.69 mmol/L in the extract group versus 2.60 mmol/L in controls. Primary funding came from the Austrian Research Promotion Agency (FFG project 850681), the University of Applied Sciences Upper Austria via the GlucoSTAR project, and the Christian Doppler Research Society, all academic sources.
One conflict is on record: co-author Marcus Iken held salaried employment with PM-International at the time of publication. The authors disclosed this; the study design was not company-controlled. Semi-independent, however, is not independent, and a single RCT on one ingredient is not evidence for the NTC architecture as a whole.
The overarching claim, that a proprietary system transports nutrients specifically to the cell at the right moment, has no independent peer-reviewed support. Mainstream nutritional science does not identify "delivery to the cellular level" as the rate-limiting step in micronutrient supplementation for people with intact gut function. Uptake depends on food matrix, dose, gut health, and individual status. The broader literature on supplements and longevity reaches a consistent finding: absorption optimization does not reliably translate into health outcomes.
The European Food Safety Authority has approved no health claim for "Nutrient Transport Concept." The nutrient-function claims FitLine legally carries, such as "Vitamin C contributes to the normal function of the immune system," stand on the presence of that nutrient in the product. NTC is not the legal basis.
How to read the claim
"Patented NTC technology" collapses two things. First: a trademark on a name, which protects the sign, not a mechanism. Second: genuine formulation patents that protect specific recipes, not the assertion that those recipes transport nutrients more effectively than alternatives.
The ingredients in FitLine products are well-documented and available from many manufacturers. What NTC adds is nomenclature. The company holds real assets: several products appear on the Cologne List, the batch-testing program operated by the German Sport University Cologne that reduces doping-contamination risk; the ATP Tour named FitLine its official sports nutrition provider through 2026; and university-level research partnerships, including a dedicated bioavailability professorship at an Austrian university of applied sciences, exist.
Those are genuine positives. They do not validate a nutrient transport mechanism. "Patented mechanism" and "commercially recognized branded concept" are not the same claim. Every lawful health statement FitLine makes under European food law rests on the nutrient present in the formula. NTC is the brand architecture around it. One is verifiable. The other is marketing.